TNFRSF11B and metabolic syndrome: Here, we evaluated the effects of dyslipidemia, alone and in combination with diabetes, on aortic and cardiac OPG and TRAIL expression and found that while diabetes is the major determinant of OPG/TRAIL tissue changes in the vessels, dyslipidemia is it in the heart.